News

25 May 2023

Oral proceedings in cases G 1/22 and G 2/22 ("Entitlement to priority")

The oral proceedings in cases G 1/22 and G 2/22 ("Entitlement to priority") before the EPO Enlarged Board of Appeal will be held on 26 May 2023

General

23 May 2023

De Clercq & Partners Participates in BIO International Convention

De Clercq & Partners is delighted to announce our participation in the esteemed BIO International Convention, one of the premier events in the biotech industry.

General

19 May 2023

De Clercq & Partners Receives Nominations for LMG Life Sciences EMEA Life Sciences Awards

We are pleased to announce that De Clercq & Partners has been nominated for the prestigious LMG Life Sciences EMEA Life Sciences Awards in multiple categories.

General

18 May 2023

De Clercq & Partners Proudly Sponsors Renson for Cycling Event in Support of Kom op tegen Kanker

We are excited to announce that De Clercq & Partners is proudly sponsoring Renson for their participation in the 1000km cycling event, organized by Kom op tegen Kanker

General

09 May 2023

De Clercq & Partners Receives Managing IP Awards 2023 Nominations, Including Kris Pappaert for Practitioner of the Year

We are thrilled to announce that De Clercq & Partners has been honored with nominations at the prestigious Managing IP Awards 2023.

Oral proceedings in cases G 1/22 and G 2/22 ("Entitlement to priority")

De Clercq & Partners Participates in BIO International Convention

De Clercq & Partners Receives Nominations for LMG Life Sciences EMEA Life Sciences Awards

De Clercq & Partners Proudly Sponsors Renson for Cycling Event in Support of Kom op tegen Kanker

De Clercq & Partners Receives Managing IP Awards 2023 Nominations, Including Kris Pappaert for Practitioner of the Year

dcp newsletter

Follow us on Instagram